Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00818584 · ClinicalTrials.gov registry record · Phase 1
An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates
A Phase 1 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT00818584: Completed Phase 1 study, sponsored by Astellas Pharma.
NCT00818584 is a Phase 1 study that has completed, run by Astellas Pharma. The registered enrollment target is 13 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00818584, a Phase 1 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study will evaluate pharmacokinetics and safety of intravenous micafungin in neonates with suspected candida infection
Interventions
- DRUG Micafungin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2007-08 |
| Est. Completion | 2007-10 |
| Phase | Phase 1 |
What the finished NCT00818584 record still lists
NCT00818584 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which Micafungin is the first listed.
NCT00818584 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00818584 about?
NCT00818584 is a clinical study titled "An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates". This study will evaluate pharmacokinetics and safety of intravenous micafungin in neonates with suspected candida infection
What is the current status of trial NCT00818584?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2007-08. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00818584?
The interventions under investigation include: Micafungin (DRUG).
Who is sponsoring clinical trial NCT00818584?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00818584's enrollment target sits among peer trials
13 1847th of 2000 higher than 149 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia